Literature DB >> 8324341

Hereditary spherocytosis with congestive heart failure: report of a case.

M Morita1, M Hashizume, T Kanematsu, K Sugimachi, K Makizumi.   

Abstract

We report herein a case of 62-year-old woman with hereditary spherocytosis (HS) and congestive heart failure (CHF). Although her history revealed jaundice in the early neonatal period, she had never undergone a physical examination and thus, the diagnosis of HS and CHF was not made until the age of 61 when she complained of dyspnea and palpitations on exertion. The CHF was subsequently found to be related to severe anemia in the presence of underlying heart disease. Splenectomy was performed in an attempt to relieve the severe hemolytic process. Following this, all the symptoms improved without the need for any cardiovascular drugs and she has been well throughout the 34 months follow up.

Entities:  

Mesh:

Year:  1993        PMID: 8324341     DOI: 10.1007/bf00309507

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  5 in total

1.  Splenic irradiation in treating warm autoimmune haemolytic anaemia.

Authors:  H Markus; J C Forfar
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-04

2.  Hypertrophic cardiomyopathy associated with hereditary spherocytosis in three generations of one family.

Authors:  V S Moiseyev; E A Korovina; E L Polotskaya; I S Poliyanskaya; V V Yazdovsky
Journal:  Lancet       Date:  1987-10-10       Impact factor: 79.321

3.  Hereditary spherocytosis in 100 children.

Authors:  H C Krueger; E O Burgert
Journal:  Mayo Clin Proc       Date:  1966-12       Impact factor: 7.616

4.  Intravenous nitroglycerin in transfusion therapy for severe anemia. Association with congestive heart failure.

Authors:  P Varriale; R P Kwa; P Vyas
Journal:  Arch Intern Med       Date:  1984-02

5.  Hereditary spherocytosis. Recent experience and current concepts of pathophysiology.

Authors:  R D Croom; C W McMillan; E P Orringer; G F Sheldon
Journal:  Ann Surg       Date:  1986-01       Impact factor: 12.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.